Quick Asked: Fulcrum Therapeutics Contact Us?
Last update: 24 Apr, 2024 
234 Views
Who is the ceo of fulcrum therapeutics? Bryan Stuart was named president and chief executive officer of Fulcrum Therapeutics in March 2021. He joined Fulcrum as chief operating officer in 2018, bringing over 20 years of industry experience, predominantly in the rare disease space.Who is the head of discovery at fulcrum? Chris Moxham, Ph.D. joined Fulcrum in January 2019 as senior vice president of Discovery Research before being promoted to chief scientific officer in January 2021. He has more than two decades of experience in drug discovery.Who is fulcrums peter thomson? Peter Thomson joined Fulcrum in 2018, bringing over 15 years of experience in the life sciences industry. Most recently, he was a consultant for three Third Rock Ventures portfolio companies, where he served as interim head of finance.Who is kim hazen at fulcrum? Kim Hazen joined Fulcrum in September 2017 with over 25 years of experience in human resources. Most recently, she was vice president of human resources at Warp Drive Bio, where she led efforts to build a drug discovery culture and core values to match with an emphasis on elite performance.
Listing Results Fulcrum Therapeutics Contact Us? Question Answers
Fulcrum Therapeutics, Inc. in Boston, MA Company Info
Fulcrum Therapeutics, Inc. is a Massachusetts Foreign Corporation filed On August 19, 2015. The company's File Number is listed as 001186204. The Registered Agent on file for this company is Kevin Gillis and is located at 29 Newbury St., Boston, MA 02116.
Fulcrum Therapeutics Home Facebook
Fulcrum Therapeutics. May 14 at 1:00 PM ·. Ally remembers trying to explain to family and friends why her son Sam never smiled as a child even though he seemed very happy. At 6 years old, Sam was diagnosed with facioscapulohumeral muscular dystrophy ( #FSHD ). Since that time, the disease has progressed, affecting Sam’s mobility and muscle
Fulcrum Therapeutics Company Profile: Stock Performance
+1 (617) 000-0000 Contact Information Website www.fulcrumtx.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Pharmaceuticals Stock Exchange NAS Primary Office 26 Landsdowne Street Cambridge, MA 02139 United States +1 (617) 000-0000 Fulcrum Therapeutics Timeline
Fulcrum Therapeutics Company Profile Office Locations
Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 a.m. ET Content Import Wed, 08/05/2020 - 07:00 Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, Augus...
Contact Us – Fulcrum Health Inc.
877-886-4941 Note: To protect the privacy of doctors and patients, please adhere to the HIPAA guidelines and do not include any specific identification information (SSN, Patient Name, Member ID, Tax ID, etc.) when contacting us via email or utilizing this contact form.. If your inquiry requires such information, please contact Provider Services at 877-886-4941 or our corporate office at 763 ...
Fulcrum Therapeutics, Inc. (FULC) Company Profile
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.
Our Approach • Fulcrum Therapeutics
Our product engine in action: Addressing the root cause of FSHD. FSHD, a rare, progressive and disabling disorder, is caused by aberrant expression of the DUX4 gene in skeletal muscle resulting in the inappropriate presence of DUX4 protein. Normally, DUX4-driven gene expression is limited to early embryonic development, after which time the DUX4 gene is silenced.